Can Fıçıcıoğlu

5.6k total citations
102 papers, 1.7k citations indexed

About

Can Fıçıcıoğlu is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Can Fıçıcıoğlu has authored 102 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Clinical Biochemistry, 45 papers in Physiology and 37 papers in Molecular Biology. Recurrent topics in Can Fıçıcıoğlu's work include Metabolism and Genetic Disorders (50 papers), Lysosomal Storage Disorders Research (29 papers) and Neonatal Health and Biochemistry (19 papers). Can Fıçıcıoğlu is often cited by papers focused on Metabolism and Genetic Disorders (50 papers), Lysosomal Storage Disorders Research (29 papers) and Neonatal Health and Biochemistry (19 papers). Can Fıçıcıoğlu collaborates with scholars based in United States, Türkiye and Italy. Can Fıçıcıoğlu's co-authors include Rebecca C. Ahrens‐Nicklas, Paige Kaplan, Barbara K. Burton, Curtis R. Coughlin, Gerard T. Berry, Nicola Longo, Claire Yager, Michael J. Bennett, Dietrich Matern and Susan E. Waisbren and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and PEDIATRICS.

In The Last Decade

Can Fıçıcıoğlu

95 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Can Fıçıcıoğlu United States 23 890 790 551 295 289 102 1.7k
Kimiyo Raymond United States 27 675 0.8× 946 1.2× 553 1.0× 280 0.9× 252 0.9× 71 1.9k
Julia B. Hennermann Germany 27 1.0k 1.1× 1.0k 1.3× 892 1.6× 288 1.0× 368 1.3× 95 2.1k
Wenjuan Qiu China 22 606 0.7× 730 0.9× 378 0.7× 283 1.0× 373 1.3× 146 1.5k
Anupam Chakrapani United Kingdom 19 1.2k 1.3× 646 0.8× 449 0.8× 389 1.3× 316 1.1× 47 1.6k
Esther M. Maier Germany 23 857 1.0× 974 1.2× 251 0.5× 221 0.7× 189 0.7× 64 1.7k
Federica Deodato Italy 23 608 0.7× 801 1.0× 640 1.2× 242 0.8× 404 1.4× 55 1.7k
Hélène Ogier de Baulny France 24 968 1.1× 1.2k 1.5× 290 0.5× 168 0.6× 258 0.9× 45 1.9k
Anupam Chakrapani United Kingdom 19 628 0.7× 546 0.7× 466 0.8× 132 0.4× 175 0.6× 57 1.2k
Anaïs Brassier France 19 389 0.4× 608 0.8× 714 1.3× 164 0.6× 168 0.6× 84 1.7k
Klary E. Niezen‐Koning Netherlands 22 522 0.6× 709 0.9× 930 1.7× 166 0.6× 395 1.4× 59 1.8k

Countries citing papers authored by Can Fıçıcıoğlu

Since Specialization
Citations

This map shows the geographic impact of Can Fıçıcıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Fıçıcıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Fıçıcıoğlu more than expected).

Fields of papers citing papers by Can Fıçıcıoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Fıçıcıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Fıçıcıoğlu. The network helps show where Can Fıçıcıoğlu may publish in the future.

Co-authorship network of co-authors of Can Fıçıcıoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Can Fıçıcıoğlu. A scholar is included among the top collaborators of Can Fıçıcıoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Fıçıcıoğlu. Can Fıçıcıoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mellor, T.K., et al.. (2025). Pancreatitis Is an Emerging Rare Complication of Classic Homocystinuria: A Case Series and Literature Review. American Journal of Medical Genetics Part A. 200(1). 155–161.
2.
Gilmor, Michelle, Raymond Wang, Can Fıçıcıoğlu, et al.. (2023). RGX-111 GENE THERAPY FOR THE TREATMENT OF SEVERE MUCOPOLYSACCHARIDOSIS TYPE I (MPS I): INTERIM ANALYSIS OF DATA FROM THE FIRST IN HUMAN STUDY. Molecular Genetics and Metabolism. 138(3). 107416–107416.
3.
4.
5.
Fıçıcıoğlu, Can, Rebecca C. Ahrens‐Nicklas, James C. DiPerna, et al.. (2020). Newborn Screening for Pompe Disease: Pennsylvania Experience. International Journal of Neonatal Screening. 6(4). 89–89. 29 indexed citations
6.
Degnan, Andrew J., Víctor Ho-Fung, Dah-Jyuu Wang, Can Fıçıcıoğlu, & Diego Jaramillo. (2020). Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients. Clinical Imaging. 63. 1–6. 11 indexed citations
7.
Cohen, Jennifer L., et al.. (2019). Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy. Orphanet Journal of Rare Diseases. 14(1). 198–198. 7 indexed citations
8.
Degnan, Andrew J., Víctor Ho-Fung, Rebecca C. Ahrens‐Nicklas, et al.. (2019). Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement. Insights into Imaging. 10(1). 70–70. 19 indexed citations
9.
Ahrens‐Nicklas, Rebecca C., Lars Schlotawa, Andrea Ballabio, et al.. (2018). Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement. Molecular Genetics and Metabolism. 123(3). 337–346. 27 indexed citations
10.
Daymont, Carrie, et al.. (2018). Failure to Thrive: An Expanded Differential Diagnosis. Journal of Pediatric Genetics. 8(1). 27–32. 4 indexed citations
11.
Miller, Judith S., Amanda Bennett, Simona Bianconi, et al.. (2018). Early Indicators of Creatine Transporter Deficiency. The Journal of Pediatrics. 206. 283–285. 10 indexed citations
12.
Fıçıcıoğlu, Can. (2017). New tools and approaches to newborn screening: ready to open Pandora's box?. Molecular Case Studies. 3(3). a001842–a001842. 12 indexed citations
13.
Berry, Susan A., Nicola Longo, George A. Díaz, et al.. (2017). Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2 months to 2 years. Molecular Genetics and Metabolism. 122(3). 46–53. 14 indexed citations
14.
Fıçıcıoğlu, Can, et al.. (2017). Intrafamilial variability in the clinical presentation of mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS). Molecular Genetics and Metabolism. 120(1-2). S46–S46.
15.
Ahrens‐Nicklas, Rebecca C., Gail B. Slap, & Can Fıçıcıoğlu. (2015). Adolescent Presentations of Inborn Errors of Metabolism. Journal of Adolescent Health. 56(5). 477–482. 8 indexed citations
16.
Fukao, Toshiyuki, Jörn Oliver Sass, Petri Kursula, et al.. (2011). Clinical and molecular characterization of five patients with succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(5). 619–624. 26 indexed citations
17.
Coughlin, Curtis R. & Can Fıçıcıoğlu. (2010). Genotype–phenotype correlations: sudden death in an infant with very‐long‐chain acyl‐CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease. 33(S3). 129–131. 10 indexed citations
18.
Fıçıcıoğlu, Can, et al.. (2010). Monitoring of Biochemical Status in Children with Duarte Galactosemia: Utility of Galactose, Galactitol, Galactonate, and Galactose 1-Phosphate. Clinical Chemistry. 56(7). 1177–1182. 21 indexed citations
19.
Fıçıcıoğlu, Can & Kristina An Haack. (2009). Failure to Thrive: When to Suspect Inborn Errors of Metabolism. PEDIATRICS. 124(3). 972–979. 12 indexed citations
20.
Fıçıcıoğlu, Can, et al.. (2007). Effect of galactose free formula on galactose-1-phosphate in two infants with classical galactosemia. European Journal of Pediatrics. 167(5). 595–596. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimiyo Raymond Breakdown of academic impact, for papers by Julia B. Hennermann Breakdown of academic impact, for papers by Wenjuan Qiu Breakdown of academic impact, for papers by Anupam Chakrapani Breakdown of academic impact, for papers by Esther M. Maier Breakdown of academic impact, for papers by Federica Deodato Breakdown of academic impact, for papers by Hélène Ogier de Baulny Breakdown of academic impact, for papers by Anupam Chakrapani Breakdown of academic impact, for papers by Anaïs Brassier Breakdown of academic impact, for papers by Klary E. Niezen‐Koning
Rankless by CCL
2026